Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Antithrombin-III activator

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Venous Thrombosis 3 D020246 ClinicalTrials
Venous Thromboembolism 3 D054556 ClinicalTrials
Venous Thrombosis 3 D020246 ClinicalTrials
Thrombophilia 3 D019851 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109204
FDA SRS LIA7Z4002P